港股详情

本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

药捷安康-B

53.750

-1.000-1.83%

成交量：29.70万

成交额：1,609.15万

市值：213.33亿

市盈率：-68.39

高：56.500

开：54.900

低：51.900

收：54.750

52周最高：58.050

52周最低：20.200

股本：3.97亿

香港流通股本：3.02亿

量比：1.89

换手率：0.10%

股息：- -

股息率：- -

每股收益(LYR):-0.786

净资产收益率：-41.98%

总资产收益率：-24.05%

市净率：37.20

市盈率(LYR):-68.39

市销率: - -

数据加载中...

总览公司新闻公告

概念

no data

没有相关数据

资金流向

资金流入：

资金流出：

新闻

药捷安康-B(02617)获纳入恒生指数系列成份股

药捷安康-B(02617.HK)发布中期业绩股东应占亏损1.23亿元同比收窄23.39%

药捷安康－Ｂ(02617)股价下跌5.023%，现价港币$52.0

阿斯达克财经

药捷安康-B(02617)获纳入恒生综合指数有望成为港股通标的

{"basename":"/hans","ssrTDKData":{"titleTemplate":"%s - 老虎证券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎证券,老虎证券开户,老虎券商,老虎证券官网,老虎证券app,tigertrade老虎证券,股票,炒股,新加坡股票交易平台,投资,投资理财","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www-web.itiger.com/hans/stock/02617"},"companyName":"老虎证券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"02617","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"02617\",,,,,undefined,":{"symbol":"02617","market":"HK","secType":"STK","nameCN":"药捷安康-B","latestPrice":53.75,"timestamp":1756109316489,"preClose":54.75,"halted":0,"volume":297000,"delay":0,"floatShares":301666673,"shares":396897633,"eps":-0.7859606657814161,"marketStatus":"未开盘","change":-1,"latestTime":"08-25 16:08:36","open":54.9,"high":56.5,"low":51.9,"amount":16091450,"amplitude":0.084018,"askPrice":53.75,"askSize":500,"bidPrice":53.7,"bidSize":500,"shortable":0,"etf":0,"ttmEps":-0.7859606657814161,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1756171800000},"marketStatusCode":0,"adr":0,"listingDate":1750608000000,"exchange":"SEHK","adjPreClose":54.75,"openAndCloseTimeList":[[1756085400000,1756094400000],[1756098000000,1756108800000]],"volumeRatio":1.8927806672324832,"lotSize":500,"spreadScale":0,"tradeCurrency":"HKD"},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"02617\",,,,,undefined,":{"symbol":"02617","floatShares":301666673,"roa":"-24.05%","roe":"-41.98%","lyrEps":-0.785961,"volumeRatio":1.8927806672324832,"shares":396897633,"dividePrice":0,"high":56.5,"amplitude":0.084018,"preClose":54.75,"low":51.9,"week52Low":20.2,"pbRate":"37.20","week52High":58.05,"institutionHeld":0,"latestPrice":53.75,"eps":-0.7859606657814161,"divideRate":0,"volume":297000,"delay":0,"ttmEps":-0.7859606657814161,"open":54.9,"prevYearClose":13.15,"prevWeekClose":54.75,"prevMonthClose":37.95,"prevQuarterClose":30.15,"fiveDayClose":54,"twentyDayClose":38.45,"sixtyDayClose":13.15},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/02617\",params:#limit:5,,,undefined,":[{"date":"2025-08-25","symbol":"02617","type":"earning","reportTimeType":"","market":"HK","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1756085400000,"name":null,"time":"","dateTimestamp":1756051200000,"actualEps":null}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"02617\",market:\"HK\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"02617\",market:\"HK\",delay:false,,,undefined,":{},"@#url:\"https://hq.skytigris.cn/hkstock/value_analysis/stock/02617\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"02617","date":"2025-08-22","current":-72.723484,"percent":0.022727,"low":-72.789898,"twenty":-59.09189,"median":-43.957869,"eighty":-39.464263,"high":-17.403134,"avg":-48.686729,"sd":12.808853,"marketCap":21730145406},"quantilePoints":[{"date":"2025-06-20","current":-17.403134,"twenty":-17.403134,"median":-17.403134,"eighty":-17.403134,"marketCap":5219203873},{"date":"2025-06-27","current":-36.622688,"twenty":-34.709071,"median":-32.493198,"eighty":-31.066553,"marketCap":11013909315},{"date":"2025-07-04","current":-44.802949,"twenty":-38.622694,"median":-35.660049,"eighty":-31.776499,"marketCap":13474674640},{"date":"2025-07-11","current":-39.630155,"twenty":-40.38446,"median":-38.336544,"eighty":-32.816725,"marketCap":11906928990},{"date":"2025-07-18","current":-43.957869,"twenty":-42.111612,"median":-39.630155,"eighty":-34.373739,"marketCap":13196846297},{"date":"2025-07-25","current":-49.067594,"twenty":-42.195906,"median":-40.285196,"eighty":-36.230637,"marketCap":14784436829},{"date":"2025-08-01","current":-50.963195,"twenty":-45.655878,"median":-41.371359,"eighty":-36.620356,"marketCap":15260713988},{"date":"2025-08-08","current":-58.015216,"twenty":-51.234741,"median":-42.017389,"eighty":-37.993773,"marketCap":17415868136},{"date":"2025-08-15","current":-66.867935,"twenty":-57.065221,"median":-42.261724,"eighty":-38.707864,"marketCap":20043330466},{"date":"2025-08-22","current":-72.723484,"twenty":-59.09189,"median":-43.957869,"eighty":-39.464263,"marketCap":21730145406}],"updateTime":1756124873103},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"02617\",pageSize:4,pageCount:1,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2562228505","title":"药捷安康-B(02617)获纳入恒生指数系列成份股","url":"https://stock-news.laohu8.com/highlight/detail?id=2562228505","media":"智通财经","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2562228505?lang=zh_cn&edition=fundamental","pubTime":"2025-08-25 22:34","pubTimestamp":1756132485,"startTime":"0","endTime":"0","summary":"智通财经APP讯，药捷安康-B(02617)发布公告，根据恒生指数有限公司于2025年8月22日公布的恒生指数系列季度检讨结果，公司已获选并将纳入包括但不限于下述恒生指数系列成份股，自2025年9月8日起生效：1.恒生综合指数;2.恒生综合行业指数-医疗保健业;3.恒生综合中小型股指数;4.恒生综合小型股指数;5.恒生医疗保健指数;6.恒生创新药指数;7.恒生港股通创新药指数;8.恒生港股通创新药精选指数;及9.恒生港股通药品及生物技术(可投资)指数。公告称，公司获纳入恒生综合指数及上述指数反映投资者的认可度上升。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1334891.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["02833","02617","MCHmain","159271","BK1161","HHImain","HSI","513600","HSImain","MHImain"],"gpt_icon":0},{"id":"2562416612","title":"药捷安康-B(02617.HK)发布中期业绩 股东应占亏损1.23亿元 同比收窄23.39%","url":"https://stock-news.laohu8.com/highlight/detail?id=2562416612","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2562416612?lang=zh_cn&edition=fundamental","pubTime":"2025-08-25 20:22","pubTimestamp":1756124552,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=ganggu","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["BK1161","CNHmain","MUCmain","UCmain","MCNHmain","02617","CYB"],"gpt_icon":0},{"id":"2562213588","title":"药捷安康－Ｂ(02617)股价下跌5.023%，现价港币$52.0","url":"https://stock-news.laohu8.com/highlight/detail?id=2562213588","media":"阿斯达克财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2562213588?lang=zh_cn&edition=fundamental","pubTime":"2025-08-25 14:05","pubTimestamp":1756101900,"startTime":"0","endTime":"0","summary":"[下跌股]药捷安康－Ｂ(02617) 股价在下午02:05比前收市价下跌5.023%，现股价为港币$52.0。至目前为止，今日最高价为$56.5，而最低价为$52.0。总成交量为15.45万股，总成交金额为港币$849.348万。","market":"sh","thumbnail":"https://plib.aastocks.com/aafnnews/image/medialib/20180126135510179_s.jpg","type":0,"news_type":0,"thumbnails":["https://plib.aastocks.com/aafnnews/image/medialib/20180126135510179_s.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.aastocks.com/tc/stocks/news/aamm-content/AAD2508252781/aamm-all-category","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"aastocks_highlight","symbols":["02617","BK1161"],"gpt_icon":0},{"id":"2561647472","title":"药捷安康-B(02617)获纳入恒生综合指数 有望成为港股通标的","url":"https://stock-news.laohu8.com/highlight/detail?id=2561647472","media":"智通财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2561647472?lang=zh_cn&edition=fundamental","pubTime":"2025-08-22 20:40","pubTimestamp":1755866401,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，8月22日，恒生指数公司宣布截至2025年6月30日之恒生指数系列季度检讨结果，其中药捷安康-B获纳入恒生综合指数，变动将于9月5日(星期五)收市后实施并于9月8日(星期一)起生效，届时沪深交易所会相应调整港股通可投资标的范围。据华泰证券研报，药捷安康-B有可能被调入港股通，因其满足了包括市值、流动性和上市时间等在内的一系列标准。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1333835.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1161","HSCEI","BK4614","HSCI","02617","HSTECH","YANG"],"gpt_icon":0}],"pageSize":4,"totalPage":16,"pageCount":1,"totalSize":62,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/market/plate/belongs/02617\",params:#limit:6,delay:false,,,undefined,":[]}}